Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

433

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

September 30, 2004

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

Brimonidine ophthalmic solution 0.1%

1 drop instilled in each eye 3 times daily (08:00, 14:00, 20:00)

DRUG

Brimonidine ophthalmic solution 0.2%

1 drop instilled in each eye 3 times daily (08:00, 14:00, 20:00)

Trial Locations (1)

Atlanta